RE: Hello all30 Oct 2024 09:23
Agreed. However, the market is indirectly or directly making it difficult for hemo to raise. Non of the big pharmas will pump millions into a company with a mcap of 20m. Might aswell just buy hemo. Because hemo is on the main market it is struggling to get the mcap and sp higher, which would help with funding.